Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Cancer missense mutations alter binding properties of proteins and their interaction networks.
Books
Dietary inflammatory index and risk of epithelial ovarian cancer in African American women.
Blood into brain after stroke.
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas.
See All 20 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas.
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas. Sarcoma. 2004; 8(4):107-11.
View in:
PubMed
authors with profiles
Andrew S Kraft